ES8505352A1 - Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol - Google Patents
Procedimiento para la obtencion de nuevos derivados de mercaptoimidazolInfo
- Publication number
- ES8505352A1 ES8505352A1 ES528581A ES528581A ES8505352A1 ES 8505352 A1 ES8505352 A1 ES 8505352A1 ES 528581 A ES528581 A ES 528581A ES 528581 A ES528581 A ES 528581A ES 8505352 A1 ES8505352 A1 ES 8505352A1
- Authority
- ES
- Spain
- Prior art keywords
- mercapto
- imidazole derivatives
- preparation
- substituted
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/53—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE MERCAPTOIMIDAZOL, DE FORMULA GENERAL (I), EN LA QUE R1 Y R2 SIGNIFICAN, AL MENOS UNO DE ELLOS, UN GRUPO HETEROARILO Y EL OTRO SIGNIFICA UN GRUPO ARILO; R3 SIGNIFICA HIDROGENO O ALQUILO INFERIOR; Y R4 SINGIFICA UN RESTO DE HIDROCARBURO ALIFATICO, Y SUS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES.CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA GENERAL (II) CON UN ALQUILENO INFERIOR.DE APLICACION EN EL TRATAMIENTO DE LAS INFLAMACIONES MOTIVADAS POR ENFERMEDADES CRONICAS REUMATICAS, ESPECIALMENTE POR LA ARTRITIS CRONICA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LU79412 | 1978-04-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8505352A1 true ES8505352A1 (es) | 1985-05-16 |
ES528581A0 ES528581A0 (es) | 1985-05-16 |
Family
ID=19728887
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES479490A Expired ES8303355A1 (es) | 1978-04-11 | 1979-04-10 | Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles. |
ES515766A Granted ES515766A0 (es) | 1978-04-11 | 1982-09-16 | Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol. |
ES528580A Expired ES8504738A1 (es) | 1978-04-11 | 1983-12-30 | Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol |
ES528579A Granted ES528579A0 (es) | 1978-04-11 | 1983-12-30 | Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol |
ES528581A Granted ES528581A0 (es) | 1978-04-11 | 1983-12-30 | Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES479490A Expired ES8303355A1 (es) | 1978-04-11 | 1979-04-10 | Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles. |
ES515766A Granted ES515766A0 (es) | 1978-04-11 | 1982-09-16 | Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol. |
ES528580A Expired ES8504738A1 (es) | 1978-04-11 | 1983-12-30 | Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol |
ES528579A Granted ES528579A0 (es) | 1978-04-11 | 1983-12-30 | Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol |
Country Status (24)
Country | Link |
---|---|
US (3) | US4461770A (es) |
EP (1) | EP0004648B1 (es) |
JP (1) | JPS54135769A (es) |
KR (2) | KR820002314B1 (es) |
AT (1) | AT376971B (es) |
AU (1) | AU532402B2 (es) |
CS (1) | CS220324B2 (es) |
CY (1) | CY1302A (es) |
DD (1) | DD142712A5 (es) |
DE (1) | DE2963572D1 (es) |
DK (1) | DK148879A (es) |
ES (5) | ES8303355A1 (es) |
FI (1) | FI65066C (es) |
GR (1) | GR71193B (es) |
HK (1) | HK87285A (es) |
HU (1) | HU182018B (es) |
IL (1) | IL57040A (es) |
MY (1) | MY8600271A (es) |
NO (1) | NO148926C (es) |
NZ (1) | NZ190153A (es) |
PL (2) | PL125972B1 (es) |
PT (1) | PT69460A (es) |
SU (2) | SU1259962A3 (es) |
ZA (1) | ZA791702B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2823197A1 (de) * | 1978-05-24 | 1979-11-29 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
DE2856909A1 (de) * | 1978-12-28 | 1980-07-17 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
DE3025484A1 (de) * | 1980-07-03 | 1982-02-04 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
US4686231A (en) * | 1985-12-12 | 1987-08-11 | Smithkline Beckman Corporation | Inhibition of 5-lipoxygenase products |
US4780470A (en) * | 1986-08-19 | 1988-10-25 | Smithkline Beckman Corporation | Inhibition of interleukin-1 by monocytes and/or macrophages |
FI91754C (fi) * | 1986-12-02 | 1994-08-10 | Tanabe Seiyaku Co | Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi |
US5955480A (en) * | 1996-11-20 | 1999-09-21 | Merck & Co., Inc. | Triaryl substituted imidazoles, compositions containing such compounds and methods of use |
EP1028954B1 (en) * | 1997-04-24 | 2003-07-02 | Ortho-McNeil Pharmaceutical, Inc. | Substituted imidazoles useful in the treatment of inflammatory diseases |
JP2002515915A (ja) * | 1997-06-30 | 2002-05-28 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 炎症性疾患の治療で有用な2−置換イミダゾール類 |
DE19842833B4 (de) * | 1998-09-18 | 2005-04-14 | Merckle Gmbh | 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung |
DE10107683A1 (de) | 2001-02-19 | 2002-08-29 | Merckle Gmbh Chem Pharm Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
DE10238045A1 (de) * | 2002-08-20 | 2004-03-04 | Merckle Gmbh Chem.-Pharm. Fabrik | 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie |
US8134029B2 (en) | 2002-09-16 | 2012-03-13 | Sunovion Pharmaceuticals Inc. | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine |
MX2008000250A (es) | 2005-07-06 | 2008-03-19 | Sepracor Inc | Combinaciones de eszopiclona y trans-4-(3,4-diclorofenil)-1,2,3,4- tetrahidro-n-metil-1-naftalenamina o trans 4-(3,4-diclorofenil)-1, 2,3,4-tetrahidro-1-naftalenamina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y |
ES2643602T3 (es) * | 2006-03-31 | 2017-11-23 | Sunovion Pharmaceuticals Inc. | Aminas y quirales |
EP1894925A1 (en) * | 2006-08-24 | 2008-03-05 | Merckle Gmbh | Imidazole compounds having an antiinflammatory effect |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2981739A (en) * | 1958-01-27 | 1961-04-25 | Diamond Alkali Co | Certain alpha-haloaldehyde addition products of ethylenethioureas and process |
US3714179A (en) * | 1970-09-08 | 1973-01-30 | Searle & Co | 1-alkyl-2-furfurylthioimidazoles and congeners |
JPS5343958B2 (es) * | 1972-07-29 | 1978-11-24 | ||
SE428686B (sv) * | 1975-08-11 | 1983-07-18 | Du Pont | Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler |
DK16778A (da) * | 1977-02-09 | 1978-08-10 | Du Pont | Imidazolderivater deres anvendelser og fremstilling |
US4159338A (en) * | 1977-02-09 | 1979-06-26 | E. I. Du Pont De Nemours And Company | Antiinflammatory-4,5-dicyclic-2-(substituted thio)-imidazoles and their corresponding sulfoxides and sulfones |
LU77703A1 (de) * | 1977-07-07 | 1979-03-26 | Ciba Geigy Ag | Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen |
DE2823197A1 (de) * | 1978-05-24 | 1979-11-29 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
US4308277A (en) * | 1978-08-10 | 1981-12-29 | Ciba-Geigy Corporation | 2,4,5-Trisubstituted imidazolines and pharmaceutical compositions containing same |
US4175127A (en) * | 1978-09-27 | 1979-11-20 | Smithkline Corporation | Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles |
DE2856909A1 (de) * | 1978-12-28 | 1980-07-17 | Schering Ag | Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate |
-
1979
- 1979-03-30 CY CY1302A patent/CY1302A/xx unknown
- 1979-03-30 EP EP79100962A patent/EP0004648B1/de not_active Expired
- 1979-03-30 DE DE7979100962T patent/DE2963572D1/de not_active Expired
- 1979-04-06 PL PL1979214745A patent/PL125972B1/pl unknown
- 1979-04-06 GR GR58824A patent/GR71193B/el unknown
- 1979-04-06 PL PL1979226123A patent/PL125882B1/pl unknown
- 1979-04-09 DD DD79212098A patent/DD142712A5/de unknown
- 1979-04-09 FI FI791158A patent/FI65066C/fi not_active IP Right Cessation
- 1979-04-10 CS CS792438A patent/CS220324B2/cs unknown
- 1979-04-10 NZ NZ190153A patent/NZ190153A/en unknown
- 1979-04-10 AU AU45994/79A patent/AU532402B2/en not_active Ceased
- 1979-04-10 AT AT0266179A patent/AT376971B/de not_active IP Right Cessation
- 1979-04-10 NO NO791228A patent/NO148926C/no unknown
- 1979-04-10 PT PT69460A patent/PT69460A/pt unknown
- 1979-04-10 IL IL57040A patent/IL57040A/xx unknown
- 1979-04-10 SU SU2747651A patent/SU1259962A3/ru active
- 1979-04-10 ES ES479490A patent/ES8303355A1/es not_active Expired
- 1979-04-10 ZA ZA791702A patent/ZA791702B/xx unknown
- 1979-04-10 HU HU79CI1925A patent/HU182018B/hu unknown
- 1979-04-10 DK DK148879A patent/DK148879A/da not_active IP Right Cessation
- 1979-04-10 KR KR7901118A patent/KR820002314B1/ko active
- 1979-04-11 JP JP4311779A patent/JPS54135769A/ja active Granted
-
1980
- 1980-05-23 SU SU802925099A patent/SU991945A3/ru active
-
1981
- 1981-11-16 US US06/321,840 patent/US4461770A/en not_active Expired - Fee Related
-
1982
- 1982-09-16 ES ES515766A patent/ES515766A0/es active Granted
- 1982-10-04 KR KR8204468A patent/KR820002315B1/ko active
-
1983
- 1983-12-30 ES ES528580A patent/ES8504738A1/es not_active Expired
- 1983-12-30 ES ES528579A patent/ES528579A0/es active Granted
- 1983-12-30 ES ES528581A patent/ES528581A0/es active Granted
-
1984
- 1984-03-09 US US06/588,025 patent/US4608382A/en not_active Expired - Fee Related
- 1984-03-09 US US06/588,024 patent/US4584310A/en not_active Expired - Fee Related
-
1985
- 1985-11-07 HK HK872/85A patent/HK87285A/xx unknown
-
1986
- 1986-12-30 MY MY271/86A patent/MY8600271A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES473451A1 (es) | Un procedimiento para la preparacion de derivados de imida- zol. | |
ES8303355A1 (es) | Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles. | |
ES8401466A1 (es) | Procedimiento para la obtencion de derivados de piridina. | |
ES8107185A1 (es) | Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas | |
ES8700660A1 (es) | Un procedimiento para la preparacion de derivados de bencimidasol. | |
ES481729A1 (es) | Procedimiento para la preparacion de derivados de 1,2-dihi- droquinolein-2-onas. | |
ES8401961A1 (es) | Procedimiento para la preparacion de nuevas n-(4-indolil-piperidino-alcohil-bencimidazolonas sustituidas. | |
ES439927A1 (es) | Procedimiento para la obtencion de 7-metoxi-6-tiatetracicli-nas. | |
ES8205791A1 (es) | Procedimiento para la preparacion de derivados de imidazol del sistema de 1,4-benzodioxan-2-ilo | |
ATE21101T1 (de) | N-iminopyridinium-betain-derivate, ihre herstellung und ihre verwendung als arzneimittel. | |
ES480113A1 (es) | Procedimiento para la preparacion de nuevos derivados de 2- iminoimidazolidina. | |
ES474367A1 (es) | Procedimiento de preparacion de nuevos derivados del benzo- (d)tiazol. | |
ES8200648A2 (es) | Procedimiento de preparacion de compuestos opacificantes para radiografia y similares | |
ATE123487T1 (de) | Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen. | |
ES8301895A1 (es) | "procedimiento para preparar nuevos acidos 2-amino-3-(halobenzoil)-metilfenilaceticos,sus esteres y sus sales metalicas". | |
ATE18211T1 (de) | Chinolinessigsaeuren und diese enthaltende pharmazeutische zubereitungen. | |
ES483247A1 (es) | Procedimiento para la obtencion de nuevos diazacicloalquenostiosustituidos | |
ES466168A1 (es) | Procedimiento para la preparacion de nuevos derivados de cromonas dotados de actividad medicamentosa | |
ES8300116A1 (es) | Procedimiento para la obtencion de nuevos derivados de la tiazolo (3,2-a)pirimidina | |
ES8103740A1 (es) | Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina | |
NO855383L (no) | Fremgangsmaate for fremstilling av piperazin-derivater. | |
ES445343A1 (es) | Procedimiento para la preparacion de derivados cuaternarios de xantinil-alcohil-nortropina. | |
ES479033A1 (es) | Un procedimiento para la preparacion de derivados de n-iminometil piperidina. | |
SE8204791D0 (sv) | Process for preparing alkoxy-vincaminic acid esters and alkoxy-apovincaminic acid esters | |
ES488388A1 (es) | Procedimiento de preparacion de derivados hidroxilados del tiazol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19991108 |